Results
(4 Answers)

Answer Explanations

  • No
    Expert 11

    sufficient data available for 1,3-D, structurally similar chemicals may not undergo identical biotransformation reactions and thus any conclusion may be highly uncertain

  • No
    Expert 6

    I think that there are enough 1,3-D 2 year carcinogenesis studies in rats and mice , and it is not necessary to rely upon cancer bioassay data for structurally similar chemicals.

  • No
    Expert 5

    The differences in response to similar chemicals can only be approximated and should not be extrapolated if human exposure is expected. For instance, 1,3-D can be genotoxic but is mostly detoxified via GSH. However, there will always be a ratio of detoxification to toxic escape of reactive species. This ratio may change with chemical structure of the compound.

  • No
    Expert 9

    In my opinion, we have an adequate database to assess the potential carcinogenicity of 1,3-D.

3 votes 2 1 vote
Expert 11
04/18/2019 02:31

Looks like agreement, I would not add the NTP studies to an evaluation due to presence of epichlorohydrin and potentially other contaminants ?

0 votes -1 1 vote
Expert 6
04/22/2019 17:33

Yes, not add the NTP studies due to the presence of epichlorohydrin in Telone II used for that study.

0
Expert 2
04/24/2019 08:06

There are contrary views throughout this survey as to the ability of a 1% epichlorohydrin impurity to explain away ALL the positive findings in the NTP bioassays.

Comments are closed for this page.